At the intersection of large-scale single cell genomics and tumor immunology.
We are committed to understanding how immune cells control malignant transformation, why this fails in cancer and how we can regain tumor control through immunotherapies.
We use large-scale single cell genomics approaches to dissect these interactions between tumor and immune cells with a focus on blood malignancies.
Our goal is to identify and develop strategies for novel immunotherapies. Join us!